• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氢氧化铝佐剂吸附乙型肝炎表面抗原的机制

Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.

作者信息

Iyer Seema, Robinett R S Robin, HogenEsch Harm, Hem Stanley L

机构信息

Department of Industrial and Physical Pharmacy, Purdue University, Robert E. Heine Pharmacy Building, Room 124, 575 Stadium Mall Drive, West Lafayette, IN 47907-1336, USA.

出版信息

Vaccine. 2004 Mar 29;22(11-12):1475-9. doi: 10.1016/j.vaccine.2003.10.023.

DOI:10.1016/j.vaccine.2003.10.023
PMID:15063571
Abstract

Hepatitis B surface antigen (HBsAg) differs from many antigens because of its associated lipid bilayer that is largely composed of phospholipids. In general, phosphate groups adsorb strongly to hydroxylated mineral surfaces by ligand exchange. The purpose of this study was to investigate the mechanism of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant with emphasis on the role of phospholipids in this adsorption. The adsorption of HBsAg by aluminum hydroxide adjuvant exhibits a high affinity adsorption isotherm. The Langmuir equation was used to calculate the adsorptive capacity (1.7 microg/microg Al), which is the amount of HBsAg adsorbed at monolayer coverage and the adsorptive coefficient (6.0 ml/microg), which is a measure of the strength of the adsorption force. The relatively high value of the adsorptive coefficient indicates that adsorption is due to a strong attractive force. Ligand exchange between a phosphate of the antigen and a surface hydroxyl of the adjuvant provides the strongest adsorption mechanism. The adsorption capacity of HBsAg was not affected by increased ionic strength indicating that electrostatic attraction is not the predominant adsorption force. Adsorption was also not affected by the addition of ethylene glycol indicating that hydrophobic interactions were not the predominant adsorption force. The strength of the adsorption force was indicated by the resistance of HBsAg to elution when exposed to interstitial fluid. Less than 5% of the HBsAg adsorbed to aluminum hydroxide adjuvant in a model vaccine was eluted during a 12 h in vitro exposure to interstitial fluid at 37 degrees C. Less than 1% of the adsorbed HBsAg in two commercial vaccines was eluted by in vitro exposure to interstitial fluid for 48 h at 37 degrees C. Thus, it was concluded that adsorption of HBsAg by aluminum hydroxide adjuvant is predominantly due to ligand exchange between the phospholipids in HBsAg and surface hydroxyls in aluminum hydroxide adjuvant.

摘要

乙肝表面抗原(HBsAg)因其相关的脂质双层而与许多抗原不同,该脂质双层主要由磷脂组成。一般来说,磷酸基团通过配体交换强烈吸附在羟基化的矿物表面。本研究的目的是研究乙肝表面抗原吸附到氢氧化铝佐剂上的机制,重点是磷脂在这种吸附中的作用。氢氧化铝佐剂对HBsAg的吸附表现出高亲和力吸附等温线。使用朗缪尔方程计算吸附容量(1.7微克/微克铝),即单层覆盖时吸附的HBsAg量,以及吸附系数(6.0毫升/微克),它是吸附力强度的一种度量。吸附系数的相对较高值表明吸附是由于强大的吸引力。抗原的磷酸与佐剂的表面羟基之间的配体交换提供了最强的吸附机制。HBsAg的吸附容量不受离子强度增加的影响,表明静电吸引不是主要的吸附力。添加乙二醇也不影响吸附,表明疏水相互作用不是主要的吸附力。当暴露于组织液时,HBsAg对洗脱的抗性表明了吸附力的强度。在37℃下体外暴露于组织液12小时期间,吸附到模型疫苗中氢氧化铝佐剂上的HBsAg不到5%被洗脱。在37℃下体外暴露于组织液48小时后,两种商业疫苗中吸附的HBsAg不到1%被洗脱。因此,得出结论,氢氧化铝佐剂对HBsAg的吸附主要是由于HBsAg中的磷脂与氢氧化铝佐剂中的表面羟基之间的配体交换。

相似文献

1
Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.氢氧化铝佐剂吸附乙型肝炎表面抗原的机制
Vaccine. 2004 Mar 29;22(11-12):1475-9. doi: 10.1016/j.vaccine.2003.10.023.
2
Mechanism of adsorption of three recombinant Streptococcus pneumoniae (Sp) vaccine antigens by an aluminum adjuvant.铝佐剂对三种重组肺炎链球菌(Sp)疫苗抗原的吸附机制。
Hum Vaccin. 2005 Mar-Apr;1(2):70-3. doi: 10.4161/hv.1.2.1592. Epub 2005 Mar 6.
3
Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.乙肝表面抗原与氢氧化铝佐剂的吸附强度对免疫反应的影响。
Vaccine. 2009 Feb 5;27(6):888-92. doi: 10.1016/j.vaccine.2008.11.078. Epub 2008 Dec 9.
4
Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response.抗原与含铝佐剂吸附强度和免疫反应之间的关系。
Vaccine. 2007 Sep 4;25(36):6618-24. doi: 10.1016/j.vaccine.2007.06.049. Epub 2007 Jul 16.
5
Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid.卵清蛋白磷酸化对含铝佐剂吸附及暴露于组织液后洗脱的影响。
Vaccine. 2005 Feb 10;23(12):1502-6. doi: 10.1016/j.vaccine.2004.08.048.
6
Relationship between tightness of binding and immunogenicity in an aluminum-containing adjuvant-adsorbed hepatitis B vaccine.含铝佐剂吸附乙肝疫苗中结合紧密性与免疫原性的关系。
Vaccine. 2009 May 21;27(24):3175-80. doi: 10.1016/j.vaccine.2009.03.054. Epub 2009 Apr 7.
7
Mechanisms of Antigen Adsorption Onto an Aluminum-Hydroxide Adjuvant Evaluated by High-Throughput Screening.通过高通量筛选评估抗原吸附到氢氧化铝佐剂上的机制。
J Pharm Sci. 2016 Jun;105(6):1829-1836. doi: 10.1016/j.xphs.2016.03.032.
8
Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant.用于疫苗开发的肉毒杆菌神经毒素重链片段的配方:吸附到含铝佐剂的机制
Vaccine. 2005 Jul 1;23(31):4029-35. doi: 10.1016/j.vaccine.2005.03.028.
9
Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker.用新型膦酸酯键联剂控制抗原与铝佐剂的结合及免疫反应。
Vaccine. 2013 Sep 13;31(40):4362-7. doi: 10.1016/j.vaccine.2013.07.019. Epub 2013 Jul 23.
10
Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid.含铝佐剂对抗原的吸附机制与间质液中体外洗脱的关系。
Vaccine. 2006 Mar 6;24(10):1665-9. doi: 10.1016/j.vaccine.2005.09.048. Epub 2005 Oct 6.

引用本文的文献

1
Engineering the hydroxyl content on aluminum oxyhydroxide nanorod for elucidating the antigen adsorption behavior.调控氢氧化铝纳米棒上的羟基含量以阐明抗原吸附行为。
NPJ Vaccines. 2022 Jun 23;7(1):62. doi: 10.1038/s41541-022-00495-9.
2
Crystalline and Amorphous Preparation of Aluminum Hydroxide Nanoparticles Enhances Protective Antigen Domain 4 Specific Immunogenicity and Provides Protection Against Anthrax.氢氧化铝纳米颗粒的结晶态和非晶态制备增强保护性抗原结构域 4 特异性免疫原性并提供炭疽保护。
Int J Nanomedicine. 2020 Jan 15;15:239-252. doi: 10.2147/IJN.S219647. eCollection 2020.
3
Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms.
乙型肝炎病毒(HBV)亚病毒颗粒作为保护性疫苗和疫苗平台。
Viruses. 2020 Jan 21;12(2):126. doi: 10.3390/v12020126.
4
Self-healing encapsulation and controlled release of vaccine antigens from PLGA microparticles delivered by microneedle patches.通过微针贴片递送的PLGA微粒实现疫苗抗原的自愈封装和控释。
Bioeng Transl Med. 2018 Oct 30;4(1):116-128. doi: 10.1002/btm2.10103. eCollection 2019 Jan.
5
Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action.解开谜团:阐明铝基佐剂的物理化学性质与其免疫作用机制之间的关系。
Allergy Asthma Clin Immunol. 2018 Nov 7;14:80. doi: 10.1186/s13223-018-0305-2. eCollection 2018.
6
From Stock Bottle to Vaccine: Elucidating the Particle Size Distributions of Aluminum Adjuvants Using Dynamic Light Scattering.从储备瓶到疫苗:利用动态光散射阐明铝佐剂的粒径分布
Front Chem. 2017 Jan 9;4:48. doi: 10.3389/fchem.2016.00048. eCollection 2016.
7
Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach.铝氧水合凝胶吸附合成 TLR7/8 配体以增强疫苗佐剂活性:一种制剂方法。
J Control Release. 2016 Dec 28;244(Pt A):98-107. doi: 10.1016/j.jconrel.2016.11.011. Epub 2016 Nov 12.
8
Patterns of binding of aluminum-containing adjuvants to Haemophilus influenzae type b and meningococcal group C conjugate vaccines and components.含铝佐剂与b型流感嗜血杆菌及C群脑膜炎球菌结合疫苗及其组分的结合模式
Biologicals. 2015 Sep;43(5):355-62. doi: 10.1016/j.biologicals.2015.06.008. Epub 2015 Jul 17.
9
Comparable quality attributes of hepatitis E vaccine antigen with and without adjuvant adsorption-dissolution treatment.经佐剂吸附-溶解处理与未经处理的戊型肝炎疫苗抗原的可比质量属性。
Hum Vaccin Immunother. 2015;11(5):1129-39. doi: 10.1080/21645515.2015.1009343.
10
Working together: interactions between vaccine antigens and adjuvants.协同作用:疫苗抗原与佐剂之间的相互作用
Ther Adv Vaccines. 2013 May;1(1):7-20. doi: 10.1177/2051013613480144.